F063 Big Rashes in Little Patients
DESCRIPTION
Rashes with inflammatory and infectious etiologies often have different clinical appearances, time courses, and associated features in infants and children than in adults. This session provides an update on new and under-recognized cutaneous presentations of pediatric infections, reactive eruptions, and inflammatory dermatoses. Case-based scenarios will be utilized to provide clinical pearls, highlight the differential diagnosis, and illustrate strategies for evaluation and management. Topics will range from common but oftentimes challenging conditions such as atopic dermatitis and papulosquamous dermatoses to recent developments in hidradenitis suppurativa and infectious rashes.
LEARNING OBJECTIVES
Recognize the spectrum of cutaneous manifestations of inflammatory disorders and infections in pediatric patients.
Identify distinctive cutaneous features and extracutaneous associations of inflammatory dermatoses, reactive eruptions, and infections in children.
Formulate appropriate management plans for pediatric rashes.
SCHEDULE
3:30 PM
Systemic treatment and complications of atopic dermatitis in children
Stephen Raymond Humphrey, MD, FAAD
3:55 PM
Q & A
Stephen Raymond Humphrey, MD, FAAD
4:00 PM
Pediatric hidradenitis suppurativa and related disorders: a clinical approach
Cathryn Joy Sibbald, MD, FAAD
4:25 PM
Q & A
Cathryn Joy Sibbald, MD, FAAD
4:30 PM
Pediatric papulosquamous puzzles and updates
Raegan D. Hunt, MD, PhD, FAAD
4:55 PM
Q & A
Raegan D. Hunt, MD, PhD, FAAD
5:00 PM
Going viral: what's new in pediatric infectious rashes
Julie V. Schaffer, MD, FAAD
5:25 PM
Q & A
Julie V. Schaffer, MD, FAAD
DIRECTOR
Julie V. Schaffer, MD, FAAD
SPEAKERS
Stephen Raymond Humphrey, MD, FAAD
Raegan D. Hunt, MD, PhD, FAAD
Cathryn Joy Sibbald, MD, FAAD
DISCLOSURES
Stephen Raymond Humphrey, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Dermsquared – Speaker/Faculty Education(Honoraria); Eli Lilly – Investigator(Grants/Research Funding); Elsevier Inc. – Independent Contractor(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding);
Raegan D. Hunt, MD, PhD, FAAD
Chiesi Farmaceutici – Advisory Board(Fees); Disc Medicine – Advisory Board(Fees); GlycosBio, Inc – Advisory Board(Stock Options), Stockholder Private Company(Stock); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Fees); Palvella Therapeutics – Investigator(Fees); Pfizer Inc. – Advisory Board(Fees); Rhythm Pharmaceuticals, Inc. – Investigator(Fees); Timber Pharmaceuticals – Data Safety Monitoring Board(Fees); UpToDate, Inc – Other(Honoraria);
Julie V. Schaffer, MD, FAAD
American Board of Dermatology – Employee(Salary); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);
Cathryn Joy Sibbald, MD, FAAD
AbbVie – Speaker(Honoraria); Incyte – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria); Miravo – Advisory Board(Honoraria); Novartis – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Speaker(Honoraria); UCB – Speaker(Honoraria);